RREB1 and neoplasm: Additionally, SLC39A3 and SLC41A1 have been reported to suppress tumor growth by downregulating Ras-responsive element-binding protein 1 (RREB1) and suppressing the activation of Akt/mTOR signaling, respectively [35,36,37].